CNBC 快讯 9月21日 16:59
Eli Lilly CEO向CNBC透露三分之一新GLP-1口服药患者选择Foundayo，药企加速扩大生产规模
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
FG 100
读报告 →
故事线索 / 详情
Eli Lilly CEO向CNBC透露三分之一新GLP-1口服药患者选择Foundayo，药企加速扩大生产规模
Eli Lilly CEO Reveals One-Third of New GLP-1 Oral Drug Patients Choose Foundayo as Pharma Companies Scale Up Production
LLY 2 篇报告
叙事时间线